|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000162337 |
Summary for LRP5 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000162337 | Gene symbol | LRP5 |
| Gene name | LDL receptor related protein 5 | |
| HGNC | 6697 | |
| Entrez ID | 4041 | |
| Gene type | protein_coding | |
| Synonyms | LRP5|LR3|BMND1|HBM|OPS|OPTA1|VBCH2|EVR4 | |
| UniProtAcc | O75197 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for LRP5 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| LRP5 | 5.96e+03 | -1.17e+00 | 2.78e-01 | -4.20e+00 | 2.72e-05 | 1.38e-04 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| LRP5 | 8.10e+03 | 1.06e+00 | 3.15e-01 | 3.36e+00 | 7.81e-04 | 2.81e-03 | READ |
Top |
Sex-biased somatic mutation for LRP5 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for LRP5 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| STAD | cg20310100 | chr11:68313739 | CGI:chr11:68312337-68313463 | promoter,gene body | 4.98e-01 | 2.61e-01 | 7.73e+00 | 1.09e-14 | 1.00e-13 | 2.37e-01 |
| THYM | cg20310100 | chr11:68313739 | CGI:chr11:68312337-68313463 | promoter,gene body | 7.41e-01 | 1.67e-01 | 8.17e+00 | 3.07e-16 | 2.13e-15 | 5.74e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg20310100 | chr11:68313739 | CGI:chr11:68312337-68313463 | promoter,gene body | 3.94e-01 | 2.18e-01 | 3.36e+00 | 7.86e-04 | 1.26e-03 | 1.76e-01 |
| LUSC | cg18031326 | chr11:68312213 | CGI:chr11:68312337-68313463 | promoter | 4.16e-01 | 6.26e-01 | -3.45e+00 | 5.55e-04 | 1.77e-03 | -2.10e-01 |
| KIRP | cg20310100 | chr11:68313739 | CGI:chr11:68312337-68313463 | promoter,gene body | 4.20e-01 | 2.61e-01 | 2.87e+00 | 4.08e-03 | 6.00e-03 | 1.59e-01 |
| CHOL | cg18031326 | chr11:68312213 | CGI:chr11:68312337-68313463 | promoter | 5.43e-01 | 8.53e-01 | -2.58e+00 | 9.87e-03 | 2.15e-02 | -3.10e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg18031326 | chr11:68312213 | CGI:chr11:68312337-68313463 | promoter | 4.85e-01 | 5.86e-01 | -4.74e+00 | 2.11e-06 | 3.79e-06 | -1.01e-01 |
| BRCA | cg20310100 | chr11:68313739 | CGI:chr11:68312337-68313463 | promoter,gene body | 3.16e-01 | 2.16e-01 | 5.25e+00 | 1.54e-07 | 3.10e-07 | 1.00e-01 |
| LUAD | cg18160691 | chr11:68314218 | CGI:chr11:68312337-68313463 | promoter,gene body | 3.32e-01 | 2.31e-01 | 2.70e+00 | 6.87e-03 | 1.20e-02 | 1.00e-01 |
| HNSC | cg18160691 | chr11:68314218 | CGI:chr11:68312337-68313463 | promoter,gene body | 4.09e-01 | 2.74e-01 | 2.35e+00 | 1.86e-02 | 2.64e-02 | 1.36e-01 |
| BLCA | cg18160691 | chr11:68314218 | CGI:chr11:68312337-68313463 | promoter,gene body | 2.93e-01 | 4.00e-01 | -2.55e+00 | 1.08e-02 | 1.83e-02 | -1.06e-01 |
| LIHC | cg18031326 | chr11:68312213 | CGI:chr11:68312337-68313463 | promoter | 7.32e-01 | 8.81e-01 | -2.91e+00 | 3.60e-03 | 6.20e-03 | -1.50e-01 |
Top |
Exon skipping events with PSI in TCGA for LRP5 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for LRP5 |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | LRP5-002 | chr11_68378904_+ | 3.09e-01 | 2.09e-01 | 2.25e+00 | 2.42e-02 | 4.96e-02 | 9.94e-02 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| BRCA | LRP5-002 | chr11_68441280_+ | 4.15e-01 | 3.30e-01 | 3.19e+00 | 1.40e-03 | 2.61e-03 | 8.46e-02 |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for LRP5 |
TFs related to LRP5.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | KLF3 | LRP5 | 2.96e+00 | 5.64e-03 | 4.35e+00 | 9.81e-01 | Female-biased |
| BRCA | NR1H4 | LRP5 | 2.58e+00 | 2.52e-03 | 4.22e+00 | 9.81e-01 | Female-biased |
| BRCA | PLAG1 | LRP5 | 2.84e+00 | 4.30e-03 | 4.32e+00 | 9.82e-01 | Female-biased |
| BRCA | TCF3 | LRP5 | 2.75e+00 | 3.76e-03 | 4.26e+00 | 9.81e-01 | Female-biased |
| BRCA | ZNF141 | LRP5 | 2.89e+00 | 3.16e-03 | 4.47e+00 | 9.86e-01 | Female-biased |
| BRCA | ZNF28 | LRP5 | 2.95e+00 | 3.47e-03 | 4.49e+00 | 9.86e-01 | Female-biased |
| BRCA | ZNF331 | LRP5 | 2.85e+00 | 4.45e-03 | 4.31e+00 | 9.81e-01 | Female-biased |
| BRCA | ZNF692 | LRP5 | 2.80e+00 | 3.48e-03 | 4.34e+00 | 9.83e-01 | Female-biased |
| BRCA | ZNF891 | LRP5 | 3.03e+00 | 6.73e-03 | 4.37e+00 | 9.80e-01 | Female-biased |
| MESO | ZNF418 | LRP5 | 1.39e+00 | 1.08e-04 | 3.84e+00 | 9.82e-01 | Female-biased |
LRP5 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for LRP5 |
RBPs related to ES in LRP5.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| COAD | SAMD4A | exon_skip_62338 | 6.67e+00 | 9.81e-01 | 6.23e+00 | 3.02e-03 | Male-biased |
| LUAD | SAMD4A | exon_skip_62338 | 6.41e+00 | 1.39e-03 | 6.95e+00 | 9.84e-01 | Female-biased |
| CHOL | RBM4 | exon_skip_62322 | 8.83e+00 | 9.87e-01 | 8.41e+00 | 8.10e-03 | Male-biased |
| ESCA | FXR2 | exon_skip_62338 | 8.03e+00 | 9.85e-01 | 7.54e+00 | 7.04e-03 | Male-biased |
| ESCA | SAMD4A | exon_skip_62338 | 6.70e+00 | 9.81e-01 | 6.09e+00 | 3.26e-03 | Male-biased |
| ESCA | ZC3H10 | exon_skip_62335 | 6.63e+00 | 6.45e-03 | 7.13e+00 | 9.81e-01 | Female-biased |
| READ | ZC3H10 | exon_skip_62335 | 6.64e+00 | 9.81e-01 | 6.17e+00 | 2.27e-03 | Male-biased |
| MESO | SAMD4A | exon_skip_62338 | 6.95e+00 | 9.85e-01 | 6.32e+00 | 7.26e-04 | Male-biased |
| GBM | SRSF7 | exon_skip_62315 | 9.50e+00 | 7.36e-03 | 9.86e+00 | 9.90e-01 | Female-biased |
| PAAD | PPRC1 | exon_skip_62322 | 1.12e+01 | 9.91e-01 | 1.08e+01 | 8.05e-03 | Male-biased |
| PAAD | RBM4 | exon_skip_62322 | 8.82e+00 | 9.93e-01 | 8.39e+00 | 1.84e-03 | Male-biased |
| KIRC | SAMD4A | exon_skip_62338 | 6.76e+00 | 9.84e-01 | 6.09e+00 | 1.79e-04 | Male-biased |
| KICH | SRSF7 | exon_skip_62315 | 9.47e+00 | 5.30e-03 | 9.84e+00 | 9.92e-01 | Female-biased |
| BLCA | FMR1 | exon_skip_62302 | 6.57e+00 | 2.48e-03 | 7.07e+00 | 9.84e-01 | Female-biased |
| SKCM | RBM4 | exon_skip_62322 | 8.51e+00 | 3.16e-03 | 8.99e+00 | 9.93e-01 | Female-biased |
| SKCM | ZC3H10 | exon_skip_62322 | 5.94e+00 | 1.52e-04 | 6.83e+00 | 9.85e-01 | Female-biased |
| HNSC | SAMD4A | exon_skip_62338 | 7.25e+00 | 9.88e-01 | 6.29e+00 | 4.67e-05 | Male-biased |
LRP5 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11604858 | chr11:67708689:A:G | - | 0.153291953720232 | 0.00820297757031352 | KIRP | Female-baised eQTL |
| rs3018160 | chr11:77926022:C:T | - | 0.142680772254842 | 0.0106903319876814 | KIRP | Female-baised eQTL |
| rs637605 | chr11:77814890:G:T | - | 0.1460966463846 | 0.0111893461811291 | KIRP | Female-baised eQTL |
| rs1790241 | chr11:77892834:C:T | - | 0.145302806365658 | 0.0126195215257913 | KIRP | Female-baised eQTL |
| rs584812 | chr11:77934141:T:C | - | 0.145302806365658 | 0.0126195215257913 | KIRP | Female-baised eQTL |
| rs581906 | chr11:77936836:C:T | - | 0.145302806365658 | 0.0126195215257913 | KIRP | Female-baised eQTL |
| rs594271 | chr11:77954560:C:T | - | 0.145302806365658 | 0.0126195215257913 | KIRP | Female-baised eQTL |
| rs11237337 | chr11:77964339:G:A | - | 0.145302806365658 | 0.0126195215257913 | KIRP | Female-baised eQTL |
| rs3018416 | chr11:77919436:G:A | - | 0.14541885195235 | 0.0126908649645713 | KIRP | Female-baised eQTL |
| rs11237342 | chr11:77982128:C:T | - | 0.144768468047075 | 0.0136683122740767 | KIRP | Female-baised eQTL |
| rs11237261 | chr11:77662888:G:A | - | 0.140218536941753 | 0.0146412850978497 | KIRP | Female-baised eQTL |
| rs113857489 | chr11:69996870:G:C | - | 0.146310901332615 | 0.0195971952028406 | KIRP | Female-baised eQTL |
| rs4520603 | chr11:67650412:C:G | - | 0.141495131930171 | 0.0202396904201674 | KIRP | Female-baised eQTL |
| rs17825097 | chr11:77745741:T:C | - | 0.136077607324413 | 0.0246558486757307 | KIRP | Female-baised eQTL |
| rs74480381 | chr11:77782958:T:C | - | 0.135207123033883 | 0.0264633229543352 | KIRP | Female-baised eQTL |
| rs728130 | chr11:77793950:T:C | - | 0.135207123033883 | 0.0264633229543352 | KIRP | Female-baised eQTL |
| rs11237300 | chr11:77806474:A:T | - | 0.135207123033883 | 0.0264633229543352 | KIRP | Female-baised eQTL |
| rs11821643 | chr11:77808031:A:T | - | 0.135207123033883 | 0.0264633229543352 | KIRP | Female-baised eQTL |
| rs1903829 | chr11:67677522:G:C | - | 0.1353264558121 | 0.0280532721231386 | KIRP | Female-baised eQTL |
| rs28819504 | chr11:67678703:G:T | - | 0.13510893818117 | 0.0282117914555096 | KIRP | Female-baised eQTL |
| rs11604041 | chr11:67682700:A:G | - | 0.13510893818117 | 0.0282117914555096 | KIRP | Female-baised eQTL |
| rs11237273 | chr11:77714745:G:C | - | 0.131389795103134 | 0.0291253950806863 | KIRP | Female-baised eQTL |
| rs12575416 | chr11:77742341:G:A | - | 0.131165895390579 | 0.0293316258563569 | KIRP | Female-baised eQTL |
| rs3888976 | chr11:67650039:C:T | - | 0.133914215363558 | 0.0316499835815417 | KIRP | Female-baised eQTL |
| rs3017493 | chr11:70819416:G:A | - | -0.123526580042669 | 0.0170841498401076 | LIHC | Female-baised eQTL |
| rs12295625 | chr11:70825755:G:A | - | 0.125263745658006 | 0.0195510877400456 | LIHC | Female-baised eQTL |
| rs7102214 | chr11:70074132:G:A | - | 0.126771845314235 | 0.0283606918317801 | LIHC | Female-baised eQTL |
| rs7937010 | chr11:73688927:T:C | - | 0.123883699463973 | 0.033865852107997 | LIHC | Female-baised eQTL |
| rs10899353 | chr11:77126506:C:T | - | 0.110783251016196 | 0.0386344047223581 | LUSC | Female-baised eQTL |
| rs10792324 | chr11:62022469:G:A | - | 0.100389058660413 | 0.0255718550311164 | BLCA | Female-baised eQTL |
| rs7103149 | chr11:62023335:G:A | - | 0.0995519108684783 | 0.0277178883999447 | BLCA | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11232537 | chr11:71202795:T:C | - | 0.0712790412505616 | 0.00761807618192888 | LIHC | Male-baised eQTL |
| rs12290227 | chr11:71188997:G:A | - | 0.0658829369674539 | 0.0150379865553733 | LIHC | Male-baised eQTL |
| rs6592447 | chr11:71930047:A:T | - | -0.0663851889227151 | 0.0181654071671845 | LIHC | Male-baised eQTL |
| rs10450664 | chr11:71925609:A:G | - | -0.0683650846170969 | 0.0200776820626345 | LIHC | Male-baised eQTL |
| rs1055452 | chr11:71996419:T:C | - | -0.0665880817875019 | 0.0221445164213489 | LIHC | Male-baised eQTL |
| rs3829215 | chr11:71996443:T:C | - | -0.0665880817875019 | 0.0221445164213489 | LIHC | Male-baised eQTL |
| rs7924834 | chr11:71933287:A:G | - | -0.0651952104011851 | 0.0258779394884737 | LIHC | Male-baised eQTL |
| rs7925604 | chr11:71930210:G:A | - | -0.0650964382456898 | 0.0262811341435187 | LIHC | Male-baised eQTL |
| rs10793015 | chr11:71989862:T:C | - | -0.0649135197091686 | 0.027105985365059 | LIHC | Male-baised eQTL |
| rs1892920 | chr11:71991385:A:G | - | -0.0649135197091686 | 0.027105985365059 | LIHC | Male-baised eQTL |
| rs7942626 | chr11:71992803:G:A | - | -0.0649135197091686 | 0.027105985365059 | LIHC | Male-baised eQTL |
| rs7121080 | chr11:71992889:G:A | - | -0.0649135197091686 | 0.027105985365059 | LIHC | Male-baised eQTL |
| rs140394636 | chr11:70835445:C:T | - | 0.0594806428516534 | 0.0283554802400542 | LIHC | Male-baised eQTL |
| rs518959 | chr11:71890059:G:A | - | 0.0648082053908322 | 0.0310239942235631 | LIHC | Male-baised eQTL |
| rs1791456 | chr11:71883842:G:C | - | 0.0615040119059501 | 0.0350877774071753 | LIHC | Male-baised eQTL |
| rs538569 | chr11:71887030:C:T | - | 0.0614025579353113 | 0.0358235492288476 | LIHC | Male-baised eQTL |
| rs2885661 | chr11:71877285:C:G | - | 0.0612042209282608 | 0.0366007181230512 | LIHC | Male-baised eQTL |
| rs2155146 | chr11:72005052:A:C | - | -0.0654209816574693 | 0.0368180747773505 | LIHC | Male-baised eQTL |
| rs1573503 | chr11:72000895:T:C | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs1541304 | chr11:72003032:T:C | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs2852365 | chr11:72004172:T:C | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs2845860 | chr11:72005615:C:T | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs2735787 | chr11:72006827:T:C | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs2155145 | chr11:72008573:G:T | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs4477459 | chr11:72009570:T:C | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs5019605 | chr11:72009733:C:G | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs5019604 | chr11:72009734:T:A | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs5019603 | chr11:72009735:C:G | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs1057992 | chr11:72016376:A:C | - | -0.062396524438673 | 0.0384056263865255 | LIHC | Male-baised eQTL |
| rs592051 | chr11:71896587:G:C | - | 0.061165415812473 | 0.0407100375512068 | LIHC | Male-baised eQTL |
| rs542097 | chr11:71890319:G:T | - | 0.0610981330997998 | 0.0413752409627034 | LIHC | Male-baised eQTL |
| rs1939241 | chr11:71994083:G:A | - | -0.0591278465617734 | 0.0416435423325703 | LIHC | Male-baised eQTL |
| rs9735988 | chr11:71907406:A:G | - | -0.0608180465907763 | 0.0429725033689634 | LIHC | Male-baised eQTL |
| rs2155142 | chr11:71931478:G:A | - | -0.0585712637146417 | 0.0453678987126403 | LIHC | Male-baised eQTL |
| rs949324 | chr11:72003480:G:C | - | -0.0600842212966499 | 0.0482122147536565 | LIHC | Male-baised eQTL |
| rs949323 | chr11:72003482:T:G | - | -0.0600842212966499 | 0.0482122147536565 | LIHC | Male-baised eQTL |
| rs949326 | chr11:72019260:C:T | - | -0.0600842212966499 | 0.0482122147536565 | LIHC | Male-baised eQTL |
| rs12361626 | chr11:63054099:G:A | - | 0.057353252756695 | 0.047699674251929 | LGG | Male-baised eQTL |
| rs59369766 | chr11:63057004:C:A | - | 0.057353252756695 | 0.047699674251929 | LGG | Male-baised eQTL |
| rs12363260 | chr11:63058416:G:T | - | 0.0571437489426517 | 0.0494462991936575 | LGG | Male-baised eQTL |
| rs76298414 | chr11:69966692:G:A | - | 0.0686969774383586 | 0.0114199324843419 | BLCA | Male-baised eQTL |
| rs12420137 | chr11:69967235:G:A | - | 0.0686969774383586 | 0.0114199324843419 | BLCA | Male-baised eQTL |
| rs74483671 | chr11:65080620:T:A | - | 0.052862699166719 | 0.0351453635694476 | BLCA | Male-baised eQTL |
| rs1723831 | chr11:73800108:A:G | - | -0.0530221834488661 | 0.0415620913462752 | BLCA | Male-baised eQTL |
| rs6592724 | chr11:77513927:G:A | - | 0.0697439706888341 | 0.0212209509069361 | LUAD | Male-baised eQTL |
| rs4930444 | chr11:67575109:G:A | - | 0.0519546823344201 | 0.0108718054108865 | COAD | Male-baised eQTL |
| rs2096586 | chr11:59163918:C:T | - | -0.0494536121974544 | 0.0136966706764686 | COAD | Male-baised eQTL |
| rs658623 | chr11:74856446:A:C | - | -0.088044764627145 | 0.0158689174421463 | COAD | Male-baised eQTL |
| rs9943597 | chr11:63557729:A:C | - | -0.0422500826723319 | 0.036622174205031 | COAD | Male-baised eQTL |
| rs7948911 | chr11:67574308:A:T | - | 0.0463354912522054 | 0.0457912138530795 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg18031326 | chr11:68312213 | promoter | -0.0549812796786597 | 3.05610800456603e-07 | -0.36561661869407147 | 3.734399837610244e-10 | LUSC |
| cg23779993 | chr11:68343122 | gene | -0.125889940906443 | 3.27354283579789e-07 | -0.35808187595901236 | 8.997875724224229e-10 | LUSC |
| cg26467269 | chr11:68411629 | gene | -0.166895830028597 | 7.48605115790127e-09 | -0.37906781673669493 | 7.369676591913111e-12 | BLCA |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg02011476 | chr11:68372728 | gene | -0.431082720208687 | 1.27018513657408e-12 | -0.7560990990828349 | 1.867857500511205e-15 | PAAD |
| cg16409259 | chr11:68349642 | gene | -0.429277187073947 | 1.75070942581305e-12 | -0.7465688837235255 | 1.8749928242053457e-15 | PAAD |
| cg26878836 | chr11:68416434 | gene,exon,CDS,UTR | -0.429277187073947 | 1.75070942581305e-12 | -0.7465688837235255 | 1.8749928242053457e-15 | PAAD |
| cg24040155 | chr11:68433267 | gene | -0.429277187073947 | 1.75070942581305e-12 | -0.7465688837235255 | 1.8749928242053457e-15 | PAAD |
| cg10771851 | chr11:68437018 | gene | -0.429277187073947 | 1.75070942581305e-12 | -0.7465688837235255 | 1.8749928242053457e-15 | PAAD |
| cg23779993 | chr11:68343122 | gene | -0.463733780126772 | 1.71852572911454e-31 | -0.9453447648929283 | 2.778387482416442e-36 | KIRP |
| cg24109739 | chr11:68413198 | gene | -0.463733780126772 | 1.71852572911454e-31 | -0.9453447648929283 | 2.778387482416442e-36 | KIRP |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of LRP5 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000162337 | LRP5 | C0001787 | Osteoporosis, Age-Related | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C0029456 | Osteoporosis | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C0029459 | Osteoporosis, Senile | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C0242852 | Proliferative vitreoretinopathy | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C0339539 | Familial Exudative Vitreoretinopathy | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C0432252 | Osteoporosis with pseudoglioma | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C0432273 | Worth disease | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C0751406 | Post-Traumatic Osteoporosis | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C1843323 | Van Buchem disease type 2 | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C1843330 | OSTEOPETROSIS, AUTOSOMAL DOMINANT 1 | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C1851402 | Exudative vitreoretinopathy 1 | 1 | CTD_human |
| ENSG00000162337 | LRP5 | C1866176 | EXUDATIVE VITREORETINOPATHY 4 (disorder) | 1 | CTD_human |